🇺🇸 levo-folinic acid in United States

33 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 5 reports (15.15%)
  2. Paraesthesia — 5 reports (15.15%)
  3. Asthenia — 3 reports (9.09%)
  4. Back Pain — 3 reports (9.09%)
  5. Diarrhoea — 3 reports (9.09%)
  6. Hypertransaminasaemia — 3 reports (9.09%)
  7. Neutropenia — 3 reports (9.09%)
  8. Pyrexia — 3 reports (9.09%)
  9. Thrombocytopenia — 3 reports (9.09%)
  10. Cholangitis — 2 reports (6.06%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is levo-folinic acid approved in United States?

levo-folinic acid does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for levo-folinic acid in United States?

National Cancer Institute, Naples is the originator. The local marketing authorisation holder may differ — check the official source linked above.